Cargando…
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice
UniPR129, an L-β-homotryptophan conjugate of the secondary bile acid lithocholic acid (LCA), acts as an effective protein-protein interaction (PPI) inhibitor of the Eph–ephrin system but suffers from a poor oral bioavailability in mice. To improve UniPR129 bioavailability, a metabolic soft spot, i.e...
Autores principales: | Ferlenghi, Francesca, Giorgio, Carmine, Incerti, Matteo, Guidetti, Lorenzo, Chiodelli, Paola, Rusnati, Marco, Tognolini, Massimiliano, Vacondio, Federica, Mor, Marco, Lodola, Alessio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779995/ https://www.ncbi.nlm.nih.gov/pubmed/35056098 http://dx.doi.org/10.3390/ph15010041 |
Ejemplares similares
-
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids
por: Guidetti, Lorenzo, et al.
Publicado: (2022) -
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase
Activation
por: Giorgio, Carmine, et al.
Publicado: (2011) -
Molecular Determinants
of EphA2 and EphB2 Antagonism
Enable the Design of Ligands with Improved Selectivity
por: Guidetti, Lorenzo, et al.
Publicado: (2023) -
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice
por: Festuccia, Claudio, et al.
Publicado: (2018) -
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin
por: Rusnati, Marco, et al.
Publicado: (2021)